| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.20B | 48.58B | 48.89B | 47.58B | 45.09B | 45.09B |
| Gross Profit | 9.84B | 10.35B | 10.31B | 10.15B | 8.37B | 10.45B |
| EBITDA | 2.57B | 3.01B | 3.18B | 3.51B | 2.26B | 3.97B |
| Net Income | 970.95M | 1.34B | 1.35B | 1.40B | 407.49M | 1.56B |
Balance Sheet | ||||||
| Total Assets | 41.87B | 42.58B | 41.57B | 44.11B | 40.52B | 41.87B |
| Cash, Cash Equivalents and Short-Term Investments | 4.69B | 4.61B | 4.51B | 6.08B | 2.01B | 4.88B |
| Total Debt | 4.15B | 4.92B | 5.28B | 6.30B | 7.39B | 7.78B |
| Total Liabilities | 15.68B | 14.91B | 15.36B | 19.04B | 16.94B | 18.46B |
| Stockholders Equity | 26.18B | 27.68B | 26.21B | 25.07B | 23.58B | 23.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.31B | 8.73M | 6.35B | -1.48B | 1.86B |
| Operating Cash Flow | 0.00 | 1.68B | 342.09M | 6.48B | -1.33B | 3.67B |
| Investing Cash Flow | 0.00 | -487.09M | 20.86M | -891.63M | -710.11M | -2.18B |
| Financing Cash Flow | 0.00 | -1.19B | -1.93B | -1.51B | -834.12M | -246.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥22.58B | -13.86 | ― | 1.87% | 4.26% | 27.55% | |
68 Neutral | ¥15.89B | 10.26 | ― | 1.74% | 7.50% | 86.59% | |
63 Neutral | ¥23.63B | 29.99 | ― | 1.87% | 1.95% | -57.52% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | ¥23.69B | 53.09 | ― | 1.32% | -0.63% | -0.70% | |
48 Neutral | ¥14.19B | 51.12 | ― | 1.61% | 2.00% | -44.01% | |
46 Neutral | ¥33.74B | 21.75 | ― | 1.65% | -1.17% | -95.57% |